Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Why do schizophrenic patients smoke?].

K Cattapan-Ludewig1, S Ludewig, E Jaquenoud Sirot

  • 1Psychiatrische Poliklinik, Inselspital, Bern, Schweiz. katja.cattapan@insel.ch

Der Nervenarzt
|September 28, 2004
PubMed
Summary

Patients with schizophrenia may use nicotine as self-medication to improve cognitive deficits and reduce antipsychotic side effects. Nicotine appears to enhance attention, memory, and information processing in these individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.

AJNR. American journal of neuroradiology·2012
Same author

Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008.

Pharmacopsychiatry·2011
Same author

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Pharmacopsychiatry·2011
Same author

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

Pharmacopsychiatry·2011
Same author

Effect on adrenal constituents of injury to the rat.

Federation proceedings·2010
Same author

Distribution of 2,2 (p-chlorophenyl) 1,1,1 trichlorethane (DDT) in tissues of rats after its ingestion.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia is associated with a high prevalence of nicotine addiction.
  • Cognitive deficits, including attention and memory impairments, are core symptoms of schizophrenia.

Purpose of the Study:

  • To explore the relationship between schizophrenia and chronic nicotine use.
  • To investigate nicotine's potential as a self-medication strategy for schizophrenia patients.

Main Methods:

  • Review of studies on nicotine's effects on cognitive functions in schizophrenia.
  • Analysis of research on nicotine's impact on preattentive information processing (P50 paradigm, prepulse inhibition).
  • Examination of nicotine's influence on antipsychotic medication metabolism and side effects.

Related Experiment Videos

Main Results:

  • Nicotine demonstrates potential to improve key cognitive functions like sustained attention, working memory, and recognition memory.
  • Evidence suggests nicotine can ameliorate deficient preattentive information processing in schizophrenia.
  • Smoking may alleviate extrapyramidal side effects of antipsychotics and induce CYP1A2, affecting drug metabolism.

Conclusions:

  • Nicotine may serve as a self-medication tool for schizophrenia patients to address cognitive deficits and medication side effects.
  • Further research into pharmacotherapeutic strategies targeting nicotinic acetylcholine receptors is warranted.